FGF7 and prostate cancer: Mutations that impact transcript levels were found in oncogenic genes such as FOS (chr14: 75745674, C -> G) and FGF7 (chr15: 49715462, C -> T), which are components of the MAP kinase signaling pathway and known to drive prostate cancer pathogenesis (Fig. 4a)34,35.